Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis

• Ngā kaituhi matua: Mehrdad Gholamzad (Author), Hussein Baharlooi (Author), Mehdi Shafiee Ardestani (Author), Zeinab Seyedkhan (Author), Maryam Azimi (Author)
• Hōputu: Pukapuka
• I whakaputaina: Tabriz University of Medical Sciences, 2021-06-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Purpose: Multiple sclerosis (MS) is a debilitating neuroinflammatory disorder of the central nervous system. It is believed to result from an impaired immune response against myelin components especially myelin oligodendrocyte glycoprotein (MOG). Some efforts have been made to bioconjugate the MOG p...